Center Laboratories, Inc. (TPEX:4123)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.25
-0.15 (-0.53%)
Nov 10, 2026, 1:30 PM CST

Center Laboratories Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6571,5161,6181,394767.72500.11
Revenue Growth
3.63%-6.29%16.06%81.58%53.51%-30.25%
Gross Profit
716.93621.26748.95618.09406.27259.66
Operating Income
55.59-361.62234.0678.56284.12-254.15
Net Income
1,0199,323-1,104-995.42102.221,816
Earnings Per Share
1.2710.90-1.41-1.360.142.52
EPS Growth
-----94.29%-53.20%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Fenghua Sector/Department
750.94576.17646.91446.06--
Pharmaceutical Division
908.37941.1971.71950.53767.8500.31
Shengzhi Venture
20.2123.1720.8216.14--
Adjustment and Write-Off
-22.87-24.26-21.57-18.72-1.52-1.64
Total
1,6571,5161,6181,394767.72500.11

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,606662.822,0503,4242,3484,849
Total Debt
4,1014,7046,5305,6213,4685,362
Net Cash (Debt)
-494.97-4,041-4,480-2,197-1,120-512.52
Net Cash Growth
------
Net Cash Per Share
-0.58-4.68-5.72-3.00-1.58-0.70

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
283.1627.16394.74-963.44-189.88-358.14
Capital Expenditures
-154.71-205.5-174.17-169.4-7.28-7.55
Free Cash Flow
128.45-178.34220.56-1,133-197.16-365.69
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.28%40.98%46.29%44.34%52.92%51.92%
Operating Margin
3.36%-23.85%14.47%5.63%37.01%-50.82%
Pretax Margin
98.55%763.01%-72.32%-79.91%-76.71%519.02%
Profit Margin
61.51%614.88%-68.22%-71.41%13.31%363.16%
FCF Margin
7.75%-11.76%13.63%-81.27%-25.68%-73.12%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.6641.6640.7141.3600.8251.799
Dividend Per Share Growth
141.17%132.88%-47.46%64.88%-54.16%83.29%
Dividend Yield
5.89%4.20%1.80%3.36%2.11%4.13%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
22.223.33--275.2216.82
Forward PE
-21.7321.7321.7321.7321.73
P/FCF Ratio
173.36-143.23---
PS Ratio
13.4420.4819.5321.9736.6461.10